DuPont Realigns Leadership Team

Taking the next steps in its transformation to a higher growth company, DuPont today is realigning its leadership team to accelerate its integrated science execution across the company and is exploring strategic alternatives for its Performance Chemicals segment.  These steps are part of DuPont's transformation to a higher growth, less cyclical company that integrates its unique scientific capabilities in biology, chemistry and materials to develop differentiated, high-value solutions in the attractive agriculture and nutrition, industrial biosciences and advanced materials markets worldwide. To accelerate the execution of its applied integrated science strategy across its businesses, James C. Collins, Jr., who currently leads the Industrial Biosciences business, will become senior vice president, reporting to DuPont Chair and CEO Ellen Kullman, and will oversee the Industrial Biosciences, Performance Polymers and Packaging & Industrial Polymers businesses.  Collins will accelerate the integration of DuPont's rapidly growing and leading industrial biotechnology into its wide-ranging advanced materials businesses, as demand for renewably sourced materials expands steadily.  A 29-year veteran of DuPont, Collins led the Danisco acquisition integration team before assuming his current role.